Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non‐small‐cell lung cancer and EGFR mutation

Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non‐small‐cell lung cancer and EGFR mutation / Occhipinti, Mario; Ferrara, R; Imbimbo, Martina; Simeon, Vittorio; Fiscon, Giulia; Marchal, Corynne; Skoetz, Nicole; Viscardi, Giuseppe. - In: COCHRANE DATABASE OF SYSTEMATIC REVIEWS. - ISSN 1469-493X. - 2022:(2022). [10.1002/14651858.CD015140]